Company intelligence / Profile preview

Sonablate

Charlotte, North Carolina, United Statessonablate.com ↗

Ownership: Private
Development stage: Other

Overview

Sonablate’s HIFU technology is FDA-cleared for prostate tissue ablation and has been used to treat over 40,000 patients worldwide. Clinical data show good medium-term disease control with preservation of sexual and urinary function, offering a minimally invasive alternative to surgery or radiation for prostate conditions.

Therapeutic areas: Men's HealthOncology
Modalities: DeviceHigh Intensity Focused Ultrasound (HIFU)
Industry: Therapeutic Medical Devices

Partnerships

Mayo Clinic

Beyond the preview

Go deeper on Sonablate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sonablate.

Explore the full profile